{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:21:35Z","timestamp":1780096895964,"version":"3.54.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.rbmo.2009.10.016","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T20:40:19Z","timestamp":1258663219000},"page":"150-155","source":"Crossref","is-referenced-by-count":35,"title":["Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS"],"prefix":"10.1016","volume":"20","author":[{"given":"Bulent O","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit","family":"Otegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Harmanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Boynukalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafettin","family":"Kirazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Yarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2009.10.016_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.ejcn.1600825","article-title":"Retinol, alpha-tocopherol and carotenoids in diabetes","volume":"53","author":"Abahusain","year":"1999","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.rbmo.2009.10.016_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2008-2156","article-title":"Retinol-binding protein 4 (RBP4) in polycystic ovary syndrome\u2013association with steroid hormones and response to pioglitazone treatment","volume":"94","author":"Aigner","year":"2009","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2006.11.073","article-title":"Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome","volume":"88","author":"Araujo Penna","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2009.10.016_bib4","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.85.7.2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2009.10.016_bib7","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1210\/jc.2007-2759","article-title":"Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition","volume":"93","author":"Barber","year":"2008","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"356","key":"10.1016\/j.rbmo.2009.10.016_bib9","first-page":"e1","article-title":"Endothelial dysfunction in PCOS: role of obesity and adipose hormones","volume":"119","author":"Carmina","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rbmo.2009.10.016_bib10","article-title":"Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome","author":"Chan","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2009.10.016_bib11","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399408000598","article-title":"Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications","volume":"10","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.rbmo.2009.10.016_bib12","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.84.11.4006","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-992923","article-title":"Cardiovascular disease risk factors in polycystic ovary syndrome","volume":"26","author":"Dokras","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.rbmo.2009.10.016_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2459\/JCM.0b013e32830b58d4","article-title":"Cardiovascular risk in women with polycystic ovary syndrome","volume":"9","author":"Giallauria","year":"2008","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.rbmo.2009.10.016_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-006-0557-0","article-title":"Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects","volume":"50","author":"Graham","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2009.10.016_bib16","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rbmo.2009.10.016_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-1016308","article-title":"Cardiovascular risk in women with polycystic ovarian syndrome","volume":"14","author":"Guzick","year":"1996","journal-title":"Semin. Reprod. Endocrinol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0143","article-title":"Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism","volume":"157","author":"Hahn","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00125-006-0303-7","article-title":"The release of the adipocytokine visfatin is regulated by glucose and insulin","volume":"49","author":"Haider","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2009.10.016_bib20","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","article-title":"Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"22","author":"Kowalska","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2009.10.016_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.rbmo.2009.10.016_bib22","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/db06-0259","article-title":"Serum visfatin increases with progressive beta-cell deterioration","volume":"55","author":"Lopez-Bermejo","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2009.10.016_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/436337a","article-title":"Metabolism: A is for adipokine","volume":"436","author":"Muoio","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.rbmo.2009.10.016_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio","year":"2004","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2009.10.016_bib25","article-title":"Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome","author":"Ozkaya","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2009.10.016_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejim.2007.05.014","article-title":"Plasma visfatin levels in normal weight women with polycystic ovary syndrome","volume":"19","author":"Panidis","year":"2008","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.rbmo.2009.10.016_bib27","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.rbmo.2009.10.016_bib28","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","article-title":"Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis","volume":"92","author":"Shroff","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib29","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","article-title":"Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin","volume":"91","author":"Tan","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib30","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jc.2007-0091","article-title":"Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids","volume":"92","author":"Tan","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.rbmo.2009.10.016_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1586\/14737159.8.3.289","article-title":"Retinol-binding protein-4 in experimental and clinical metabolic disease","volume":"8","author":"von Eynatten","year":"2008","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.rbmo.2009.10.016_bib32","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2009.10.016_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1472-6483(10)62130-X","article-title":"Risk factors for the deterioration of glucose metabolism in polycystic ovary syndrome","volume":"9","author":"Wang","year":"2004","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2009.10.016_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-006-0006-3","article-title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome","volume":"30","author":"Weiping","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2009.10.016_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.rbmo.2009.10.016_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2009.10.016_bib37","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jc.87.8.3871","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"Suppl. 2","key":"10.1016\/j.rbmo.2009.10.016_bib38","first-page":"161","article-title":"Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome","volume":"59","author":"Zwirska-Korczala","year":"2008","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264830900159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264830900159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T23:33:42Z","timestamp":1558654422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264830900159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S147264830900159X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2009.10.016","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}